Skip to main navigation
Skip to search
Skip to main content

Research Profiles at Washington University School of Medicine Home

Help & FAQ

Home
Profiles
Departments, Divisions and Centers
Research output

Search by expertise, name or affiliation

Natalizumab and PML: A risky business?

David B. Clifford

Department of Neurology
Institute of Clinical and Translational Sciences
Division of AIDS and Infectious Disease
Institute for Public Health

Research output: Contribution to journal › Comment/debate

13 Scopus citations

Overview
Fingerprint

Fingerprint

Dive into the research topics of 'Natalizumab and PML: A risky business?'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Powered by Pure, Scopus & Elsevier Fingerprint Engine™ © 2022 Elsevier B.V

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

About web accessibility